📈 Price History

Ratio Health

— Excellent

— Good

— Average

— Poor

By Category

📊 Peer Medians

About

Central Garden & Pet Company produces and distributes various products for the lawn and garden, and pet supplies markets in the United States. It operates through two segments: Pet and Garden. The Pet segment provides dog and cat supplies, such as dog treats and chews, toys, pet beds and containment, grooming items, waste management, and training pads; supplies for aquatics, small animals, reptiles, and pet birds, including toys, enclosures, habitats, bedding, and food and supplements; products for equine and livestock; animal and household health and insect control products; aquariums and terrariums, including fixtures and stands, water conditioners and supplements, water pumps and filters, and lighting systems and accessories; and live fish and small animals, as well as outdoor cushions. This segment sells its products under the Aqueon, Cadet, Comfort Zone, Farnam, Four Paws, K&H Pet Products, Kaytee, Nylabone, and Zilla brands. Its Garden segment offers lawn and garden supplies products that include grass seed; vegetable; flower and herb packet seed; wild bird feed, bird feeders, bird houses, and other birding accessories; fertilizers; decorative products; live plants; and weed and grass, as well as other herbicides, insecticide, and pesticide products. This segment sells its lawn and garden supplies products under the Amdro, Ferry-Morse, Pennington, and Sevin brands. The company sells its products to independent distributors, big-box retailers, national and regional retail chains, eCommerce and online retailers, grocery stores, nurseries, and mass merchants. Central Garden & Pet Company was founded in 1955 and is headquartered in Walnut Creek, California.

Key Ratios Snapshot

📈 Growth Pattern

⚡ Latest Quarter —

See full financials →

📊 Quick Scorecard

Loading…

⭐ Superinvestors Holding CENT

View All Superinvestors →

Manager	Shares	Value	% of Fund	Period
Jim Simons Renaissance Technologies LLC	181.8K	$6.7M	0.01%	Mar 2026
Steve Cohen Point72 Asset Management	6.4K	$236K	0.00%	Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔍 Concall Decoded

🎙 Management Tone Tracker Mixed ↓ Deteriorating 4 quarters analysed

Q3 2025

Confident Specific

Management repeatedly used phrases like 'solid third quarter', 'record Q3 and year-to-date GAAP and non-GAAP EPS', 'significant margin expansion', and 'remain confident in our full-year outlook', while also acknowledging 'complex and fluid macro-economic environment', 'tariff-related inflationary pressures', and 'extended cool and rainy weather'.

Q4 2025

Mixed

Management highlights record EPS, EBITDA, and gross margin expansion, signaling confidence in execution and strategy. However, they also express caution about top-line challenges, tariff headwinds, and consumer bifurcation, using phrases like 'extremely challenging' and 'modest' margin expansion.

Q1 2026

Confident Specific

Management expressed confidence by reaffirming EPS guidance of $2.70 or better, highlighting improved gross margins and disciplined execution. They attributed sales declines primarily to timing and portfolio optimization, providing specific breakdowns and avoiding vague language.

Q2 2026 latest

Mixed

Management highlighted a record quarter with specific figures (sales +9%, operating margin 12.6%, EPS $1.28) but tempered confidence with repeated caveats about weather dependency and the need to see May play out before adjusting guidance.

Guidance Reliability Pending · <3Q data

Investor Lens

The investment thesis is strengthened by a record Q2 that shows the operating model is delivering margin expansion and top-line growth. The JV and consolidations reduce complexity and free up management focus on higher-margin brands. However, the second half outlook remains tied to May weather and raw material costs, which could pressure garden margins. The maintained $2.70 EPS guidance provides a baseline, but upside depends on spring sell-through. Key items to watch next quarter: May garden consumption, pet category momentum, and the financial impact of the JV as it begins to integrate.

AI-generated concall tone analysis · Updated 2026-06-09 · Not investment advice

🎙 Management Tone Mixed ↓ Deteriorating 4 quarters Full tone analysis in Intelligence →

📊 MIXED Record Q2 FY2026: Sales up 9% to $906M, EPS $1.28, guidance maintained

Revenue & Profitability

Net sales were $906M, up 9% year-over-year. Operating income was $114M, up from $93M, and net income was $79M compared to $64M. Diluted EPS was a record $1.28. Adjusted EBITDA was $139M, with margin of 15.4% vs 14.8%.

Outlook

Management is cautiously optimistic, noting strong consumption when weather is favorable, but the critical May selling period remains ahead. Consumers are value-seeking, driving channel shifts to mass, club, and e-commerce, as well as growth in private label. Raw material inflation (urea, fuel) is a headwind but considered manageable.

Growth Drivers

Key growth levers include strength in pet consumables (dog & cat, equine, professional) and garden categories (grass seed, fertilizer, wild bird). Distribution gains and market share wins were achieved in both segments. Innovation (e.g., Nylabone with real meat, The Rebels grass seed) and private label programs are also contributing.

Balance Sheet & CapEx

Capital expenditure guidance for fiscal 2026 is $50M-$60M, focused on maintenance and targeted productivity/growth initiatives. This was consistent with the prior year's CapEx of around $10M per quarter.

Margins

Gross margin was 33.1%, up 30 bps, supported by productivity gains and favorable mix in pet. Operating margin improved to 12.6% vs 11.2%. Pet segment operating margin rose to 16.3% (from 13.4%) while Garden operating margin remained relatively consistent at 15.4%. SG&A declined as a percentage of sales to 20.5%.

Key Risks

Key risks include weather dependence (especially May for live goods), raw material inflation (urea, fuel) due to geopolitical events, promotional intensity at retail, and consumer value-seeking behavior. The joint venture is expected to be slightly dilutive in the near term ($0.03-$0.05 EPS in H2).

Generated by AI · Q2 2026 results · Not investment advice

✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter

🔍

🔎 See cross-company document search → ?

📞 Earnings Call Transcripts (5)

Q3 2026 Q3 2026 2026-08-05

Organic sales grew 2% year-over-year, with margin expansion and strong execution in both Pet and Garden. The TRIXIE acquisition will expand international reach, and guidance for fiscal 2026 non-GAAP EPS was raised to $2.85 or better. Cash flow and liquidity remain robust.

Q2 2026 Q2 2026 2026-05-06

Record Q2 and first half driven by strong sales, margin expansion, and innovation in both Pet and Garden segments. Guidance for fiscal 2026 EPS of $2.70 or better is maintained, with a cautious outlook due to weather and input cost risks.

Q1 2026 Q1 2026 2026-02-04

First quarter saw a 6% sales decline due to shipment timing and portfolio optimization, but gross margin improved and EPS exceeded expectations. Pet and garden segments gained share in key categories, and guidance for FY26 EPS was reaffirmed at $2.70 or better.

Q4 2025 Q4 2025 2025-11-24

Record fiscal 2025 results featured margin expansion, record EPS, and strong cash flow, despite a 2% sales decline from portfolio optimization and product transitions. Fiscal 2026 guidance targets further margin gains and $2.70+ EPS, with continued investment in innovation and e-commerce.

Q3 2025 Q3 2025 2025-08-06

Record Q3 EPS and margin expansion were achieved despite sales declines from product exits and weather headwinds. Guidance for FY25 non-GAAP EPS is reaffirmed at $2.60, with tariff impacts expected to intensify in Q4. Strong cash flow enabled share buybacks and ongoing investment in innovation.

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯

Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.

📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.